Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Rare disease

Neuronal ceroid lipofuscinosis

  • 1 clinical trial
Quick filters

1 Clinical trial

Neuronal ceroid lipofuscinosis

Not yet recruiting

First study of TTX-381 gene therapy safety in patients with eye problems caused by CLN2 disease (Neuronal Ceroid Lipofuscinosis Type 2)

InvestigationalNo placebo
Countries:GermanyGermany
  • Participants:0–17 years
  • Substances:TTX-381
  • Sponsor:Tern Therapeutics LLC
See all trials →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.